iSELECT FUND

Type

Venture Capital

Status

Active

Location

St. Louis, United States

Total investments

78

Average round size

12M

Portfolio companies

50

Rounds per year

6.50

Lead investments

6

Follow on index

0.36

Exits

4

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareAnalyticsHealth CareSaaSLife ScienceTherapeuticsAgTechAgricultureFarming

Summary

In 2013 was created iSELECT FUND, which is appeared as VC. The leading representative office of defined VC is situated in the St Louis. The company was established in North America in United States.

The increased amount of exits for fund were in 2019. The average startup value when the investment from iSELECT FUND is 1-5 millions dollars. The top activity for fund was in 2015. Opposing the other organizations, this iSELECT FUND works on 27 percentage points less the average amount of lead investments. The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 5 - 10 millions dollars. Considering the real fund results, this VC is 13 percentage points less often commits exit comparing to other organizations.

Among the most successful fund investment fields, there are Agriculture, SaaS. Among the various public portfolio startups of the fund, we may underline Benson Hill Biosystems, ImmunoPhotonics, Gremlin Social For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the iSELECT FUND, startups are often financed by BioGenerator, Missouri Technology Corporation, Y Combinator. The meaningful sponsors for the fund in investment in the same round are Cultivation Capital, Missouri Technology Corporation, BioGenerator. In the next rounds fund is usually obtained by Cultivation Capital, Argonautic Ventures, Missouri Technology Corporation.

The fund was created by Michael Kime. Besides them, we counted 8 critical employees of this fund in our database.

Show more

Investor highlights

Industry focus
AgricultureHealthcareFoodtech
Stage focus
Series ASeries B
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 3800000
Fund raised date
2019-07-16

Analytics

Total investments
78
Lead investments
6
Exits
4
Rounds per year
6.50
Follow on index
0.36
Investments by industry
  • Biotechnology (33)
  • Health Care (24)
  • Agriculture (23)
  • Software (16)
  • Farming (16)
  • Show 84 more
Investments by region
  • United States (77)
  • Australia (1)
Peak activity year
2015
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
28M
Group Appearance index
0.87
Avg. company exit year
8
Avg. multiplicator
2.26
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
ImmunoPhotonics 06 Apr 2022 Biotechnology, Health Care, Life Science Early Stage Venture 21M United States, Missouri, Columbia
Triplebar 25 Oct 2023 Biotechnology, Health Care, Therapeutics Early Stage Venture 20M United States, California, Emeryville

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.